Package 0078-0364-05

Brand: lotrel

Generic: amlodipine besylate and benazepril hydrochloride
NDC Package

Package Facts

Identity

Package NDC 0078-0364-05
Digits Only 0078036405
Product NDC 0078-0364
Description

100 CAPSULE in 1 BOTTLE (0078-0364-05)

Marketing

Marketing Status
Discontinued 2026-03-31
Brand lotrel
Generic amlodipine besylate and benazepril hydrochloride
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "b9db75d9-9d1e-4b2d-9876-5f5520feaecc", "openfda": {"unii": ["864V2Q084H", "N1SN99T69T"], "rxcui": ["898342", "898344", "898346", "898348", "898353", "898355", "898356", "898358"], "spl_set_id": ["94ae6054-b7ae-4212-a567-4f803af8f2c7"], "manufacturer_name": ["Novartis Pharmaceuticals Corporation"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 CAPSULE in 1 BOTTLE (0078-0364-05)", "package_ndc": "0078-0364-05", "marketing_end_date": "20260331", "marketing_start_date": "19950303"}], "brand_name": "Lotrel", "product_id": "0078-0364_b9db75d9-9d1e-4b2d-9876-5f5520feaecc", "dosage_form": "CAPSULE", "pharm_class": ["Angiotensin Converting Enzyme Inhibitor [EPC]", "Angiotensin-converting Enzyme Inhibitors [MoA]", "Calcium Channel Antagonists [MoA]", "Calcium Channel Blocker [EPC]", "Cytochrome P450 3A Inhibitors [MoA]", "Decreased Blood Pressure [PE]", "Dihydropyridine Calcium Channel Blocker [EPC]", "Dihydropyridines [CS]"], "product_ndc": "0078-0364", "generic_name": "amlodipine besylate and benazepril hydrochloride", "labeler_name": "Novartis Pharmaceuticals Corporation", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Lotrel", "active_ingredients": [{"name": "AMLODIPINE BESYLATE", "strength": "10 mg/1"}, {"name": "BENAZEPRIL HYDROCHLORIDE", "strength": "20 mg/1"}], "application_number": "NDA020364", "marketing_category": "NDA", "marketing_end_date": "20260930", "marketing_start_date": "19950303"}